SWK Holdings Corporation (SWKH)
| Market Cap | 182.25M |
| Revenue (ttm) | 35.20M |
| Net Income (ttm) | 9.34M |
| Shares Out | 12.91M |
| EPS (ttm) | 0.72 |
| PE Ratio | 18.97 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 25 |
| Last Price | $13.68 |
| Previous Close | $14.07 |
| Change ($) | -0.39 |
| Change (%) | -2.77% |
| Day's Open | 14.25 |
| Day's Range | 13.68 - 14.74 |
| Day's Volume | 8,966 |
| 52-Week Range | 6.12 - 16.24 |
DALLAS, Feb. 16, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, tod...
MOUNT OLIVE, N.J., Jan. 4, 2021 /PRNewswire/ -- Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation...
DALLAS, Dec. 24, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, to...
DALLAS, Nov. 13, 2020 /PRNewswire/ -- Corporate Highlights Enteris BioPharma, Inc., ("Enteris") a wholly-owned subsidiary of SWK Holdings, recognized $2.5 million in milestone revenue under th...
DALLAS, Nov. 11, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, ...
DALLAS, Oct. 27, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, to...
DALLAS, Sept. 15, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer,...
BOONTON, N.J., Sept. 15, 2020 /PRNewswire/ -- Enteris BioPharma, Inc.
DALLAS, Sept. 9, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, ...
SWK Holdings Corporation (SWKH) CEO Winston Black on Q2 2020 Results - Earnings Call Transcript
DALLAS, Aug. 14, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced that the Company will host a conference call and live...
DALLAS, June 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today that Chairman and CEO Winston Black will presen...
About SWKH
SWK Holdings Corporation, a specialized finance company, focuses on the healthcare sector. The company operates through two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory s... [Read more...]
| Industry Asset Management | IPO Date Sep 22, 1999 |
| CEO Winston Lee Black III | Employees 32 |
| Stock Exchange NASDAQ | Ticker Symbol SWKH |
Financial Performance
In 2019, SWK Holdings's revenue was $30.75 million, an increase of 18.30% compared to the previous year's $25.99 million. Earnings were $23.83 million, an increase of 284.63%.
Analyst Forecasts
According to 2 analysts, the average rating for SWK Holdings stock is "Buy." The 12-month stock price forecast is 23.00, which is an increase of 68.13% from the latest price.